271 related articles for article (PubMed ID: 27018597)
21. Inhibition of iNOS alleviates cognitive deficits and depression in diabetic mice through downregulating the NO/sGC/cGMP/PKG signal pathway.
Zhou XY; Zhang F; Ying CJ; Chen J; Chen L; Dong J; Shi Y; Tang M; Hu XT; Pan ZH; Xu NN; Zheng KY; Tang RX; Song YJ
Behav Brain Res; 2017 Mar; 322(Pt A):70-82. PubMed ID: 28077315
[TBL] [Abstract][Full Text] [Related]
22. Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression.
Dong L; Zhou Q; Zhang Z; Zhu Y; Duan T; Feng Y
J Obstet Gynaecol Res; 2012 Aug; 38(8):1077-85. PubMed ID: 22540333
[TBL] [Abstract][Full Text] [Related]
23. Metformin exacerbates and simvastatin attenuates myelin damage in high fat diet-fed C57BL/6 J mice.
Ciric D; Martinovic T; Petricevic S; Trajkovic V; Bumbasirevic V; Kravic-Stevovic T
Neuropathology; 2018 Oct; 38(5):468-474. PubMed ID: 30123961
[TBL] [Abstract][Full Text] [Related]
24. Troxerutin protects against high cholesterol-induced cognitive deficits in mice.
Lu J; Wu DM; Zheng ZH; Zheng YL; Hu B; Zhang ZF
Brain; 2011 Mar; 134(Pt 3):783-97. PubMed ID: 21252113
[TBL] [Abstract][Full Text] [Related]
25. The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment.
de Bruin NMWJ; van Loevezijn A; Wicke KM; de Haan M; Venhorst J; Lange JHM; de Groote L; van der Neut MAW; Prickaerts J; Andriambeloson E; Foley AG; van Drimmelen M; van der Wetering M; Kruse CG
Neurobiol Learn Mem; 2016 Sep; 133():100-117. PubMed ID: 27344942
[TBL] [Abstract][Full Text] [Related]
26. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats.
Camarasa J; Marimón JM; Rodrigo T; Escubedo E; Pubill D
Eur J Pharmacol; 2008 Jul; 589(1-3):132-9. PubMed ID: 18582864
[TBL] [Abstract][Full Text] [Related]
27. Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice.
Allard JS; Perez EJ; Fukui K; Carpenter P; Ingram DK; de Cabo R
Behav Brain Res; 2016 Mar; 301():1-9. PubMed ID: 26698400
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
29. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
31. Stress during a critical postnatal period induces region-specific structural abnormalities and dysfunction of the prefrontal cortex via CRF1.
Yang XD; Liao XM; Uribe-Mariño A; Liu R; Xie XM; Jia J; Su YA; Li JT; Schmidt MV; Wang XD; Si TM
Neuropsychopharmacology; 2015 Mar; 40(5):1203-15. PubMed ID: 25403725
[TBL] [Abstract][Full Text] [Related]
32. Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.
Assaf F; Fishbein M; Gafni M; Keren O; Sarne Y
Behav Brain Res; 2011 Jun; 220(1):194-201. PubMed ID: 21315768
[TBL] [Abstract][Full Text] [Related]
33. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
34. Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2/HO-1 pathway.
FangFang ; Li H; Qin T; Li M; Ma S
Metab Brain Dis; 2017 Apr; 32(2):385-393. PubMed ID: 27761760
[TBL] [Abstract][Full Text] [Related]
35. Chemobrain: a systematic review of structural and functional neuroimaging studies.
Simó M; Rifà-Ros X; Rodriguez-Fornells A; Bruna J
Neurosci Biobehav Rev; 2013 Sep; 37(8):1311-21. PubMed ID: 23660455
[TBL] [Abstract][Full Text] [Related]
36. Systemic cisplatin exposure during infancy and adolescence causes impaired cognitive function in adulthood.
John T; Lomeli N; Bota DA
Behav Brain Res; 2017 Feb; 319():200-206. PubMed ID: 27851909
[TBL] [Abstract][Full Text] [Related]
37. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
38. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain.
Park HS; Kim CJ; Kwak HB; No MH; Heo JW; Kim TW
Neuropharmacology; 2018 May; 133():451-461. PubMed ID: 29477301
[TBL] [Abstract][Full Text] [Related]
39. Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPKα-regulated Autophagy Induction.
Li J; Gui Y; Ren J; Liu X; Feng Y; Zeng Z; He W; Yang J; Dai C
Sci Rep; 2016 Apr; 6():23975. PubMed ID: 27052588
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.
Lomeli N; Di K; Czerniawski J; Guzowski JF; Bota DA
Free Radic Biol Med; 2017 Jan; 102():274-286. PubMed ID: 27908784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
